Abstract
Since the first liver transplant was performed in 1963, great advancements have been made in hepatic transplantation. Surgical techniques have been revised and improved, diagnostic methods for identifying and preventing infections have been developed, and a more conservative use of immunosuppressive agents has resulted in better long-term posttransplant outcomes. A total of 7841 liver transplantations were performed in the United States in 2016, resulting in greater than 85% survival at 1 year posttransplant. However, technical surgical complications, infections, rejections, and chronic medical conditions persist. This article discusses the infectious complications and malignancies that may arise after liver transplantation.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 381-393 |
| Number of pages | 13 |
| Journal | Anesthesiology Clinics |
| Volume | 35 |
| Issue number | 3 |
| DOIs | |
| State | Published - Sep 2017 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2017 Elsevier Inc.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Immunosuppression
- Infection
- Liver transplantation
- Malignancy
- Mortality
Fingerprint
Dive into the research topics of 'Infectious Complications and Malignancies Arising After Liver Transplantation'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS